Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-17-000346
Filing Date
2017-04-05
Accepted
2017-04-05 16:32:25
Documents
1
Period of Report
2014-09-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_4652.html 4  
1 PRIMARY DOCUMENT doc4_4652.xml 4 6014
  Complete submission text file 0001638599-17-000346.txt   7564
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IBIOPHARMA, INC. 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address
GENERAL HILL (Ret) JAMES T. (Reporting) CIK: 0001441718 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35023 | Film No.: 17742953